Growing old is a fact of life for all living creatures. Humans have been fighting the signs and symptoms of aging for decades; with scientists focused on finding new ways to cosmetically prevent the physical effects of aging and to develop treatments for age-related diseases and conditions.
With the emerging field of anti-aging, research is now looking further upstream to focus on the root cause of aging and to leverage new and innovative technology in an effort to turn back the clock on age-related diseases. The goal of extending life expectancy—or at least allowing humans to live healthier into old age—has already garnered the attention of several tech billionaires including Jeff Bezos and Peter Thiel. As a result, start-ups in this space are popping up more frequently and attracting interest from VCs.
Join us to explore the emerging field of anti-aging and the revolutionary technologies employed to both understand and address the aging process. We’ll hear from industry experts, start-ups and investors on what is driving innovation, the opportunities for biotech start-ups, the investment trends shaping the sector and how lifespan technology can successfully fit into a biotech model designed with a limited window of time for investment. We’ll also discuss ethical implications and societal impacts surrounding anti-aging interventions.